ClinicalTrials.gg
RecruitingNCT07853352GB- PPT&PCBTUpdated Oct 1, 2026

Effectiveness of Group-based Positive Psychotherapy and Positive Cognitive Behavioral Therapy in Improving Psychological Distress, Coping Strategies, and Well-being Among Incarcerated Individuals.

An interventional study of Positive Psychotherapy (PPT) and Positive Cognitive Behavioral Therapy (PCBT) in Psychological Distress, Quality of Life and Coping Strategies, sponsored by Bahria University. Recruiting at 4 sites in Pakistan. Open to participants aged 13 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Bahria University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Dec 2025, registered Sep 2026).
  • Started Dec 2025; still recruiting 11 months later.
Updated Oct 1, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
13 Years to 40 Years
Sex
All
01

Study summary

The foremost idea of the proposed research is to highlight the impact of psychological distress and coping strategies on the wellbeing of individuals in incarceration. In Pakistan, there is limited literature available to support the psychological wellbeing of individuals in incarceration. The current research will not only explore the impact of psychological distress and coping strategies on the wellbeing of inmates. In addition, the research will also aim to investigate the effectiveness of group-based interventions, which includes Positive Psychotherapy (PPT) and Positive Cognitive Behavioral Therapy (PCBT) in improving psychological distress, coping strategies, and wellbeing of Incarcerated Individuals.

02

Conditions studied

  • Psychological Distress
  • Quality of Life
  • Coping Strategies

Keywords

  • PPT
  • PCBT
  • Incarcerated Individuals
  • Psychological Distress
  • Quality of Life
03

In context

Lead sponsor

Bahria University is the lead sponsor of 36 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals with first time offense
  • Minimum duration of incarceration: 3 months.
  • Must have a score falling in the mild to severe range for depression and/or anxiety and a score below 6.4 on the PERMA profiler.
  • Urdu understanding and ability to comprehend measures

Exclusion criteria

Exclusion Criteria:

  • not falling in the age criteria
  • having a history of repeated crime
  • under any pharmacological and psychological treatment.
  • Individuals with types of crimes such as murder and rape were not included.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Positive Psychotherapy (PPT)

    The participants in this experimental group will receive intervention; treatment plan based on a strong foundation of positive psychology for enhancing positive emotions, engagement, relationships, meaning, and accomplishment by building up individuals' inner skill sets, including strengths and achievements, to manage their psychological distress to improve their quality of life.

    Behavioral: Positive Psychotherapy (PPT)

  • Experimental
    Positive Cognitive Behavioral Therapy (PCBT)

    In this experimental group, the participants will receive an intervention plan based on incorporating positive psychology and solution-focused brief therapy (Bannink \& Geschwind, 2021) within the model of cognitive behavioral therapy.

    Behavioral: Positive Cognitive Behavioral Therapy (PCBT)

  • Other
    Waitlist Control Group

    The participants who will be assigned to this group will be on the waitlist during the active research period. Post-test will be collected at the time as the experimental group to compare the results. After the completion of research data, waitlist participants will be offered and invited to enrol for intervention.

    Other: Waitlist Control Group

Interventions

  • BehavioralPositive Psychotherapy (PPT)

    The participants in this experimental group will receive intervention; treatment plan based on a strong foundation of positive psychology for enhancing positive emotions, engagement, relationships, meaning, and accomplishment by building up individuals' inner skill sets, including strengths and achievements, to manage their psychological distress to improve their quality of life. The intervention plan is designed to employ 8 PPT exercises, including a positive introduction, three good things, using character strengths in a way, positive cognitive reappraisal, active constructive responding, savouring, gratitude letters and forgiveness letters.

  • BehavioralPositive Cognitive Behavioral Therapy (PCBT)

    In this experimental group, the participants will receive an intervention plan based on incorporating positive psychology and solution-focused brief therapy (Bannink \& Geschwind, 2021) within the model of cognitive behavioral therapy. The 8-week session plan emphasizes on what is better, exploring the existing resources and self-monitoring to improve wellbeing and quality of life.

    Also known as: PCBT

  • OtherWaitlist Control Group

    Participants allocated to this group will be considered as on the waitlist during the active data collection period. This group will serve as a comparison group to see the effectiveness of PPT and PCBT.

06

What researchers measure

Primary outcomes

  1. Psychological Distress

    Depression, Anxiety and Stress Scale DASS-21 is a self-report questionnaire designed to examine three negative emotional states. The scale has 21 items, with 7 items for each subdomain.

    Time frame: Baseline and 8th Week

  2. PERMA Profiler

    23-item questionnaire for assessing five elements, including positive emotion, engagement, relationships, meaning, accomplishment), along with negative emotion and health.

    Time frame: Baseline and 8th Week

  3. Brief Coping Orientation to Problems Experienced Inventory

    Self-report 28-item questionnaire to measure coping with sress

    Time frame: Baseline and 8th Week

Secondary outcomes

  1. Character Strengths

    72-item Character Strength Survey to assess 24 universal character strengths.

    Time frame: Baseline and 8th week

07

Study locations

1 of 4 sites recruiting
  • Central Prison and Correctional Facility for Women Karachi
    Karachi, Sindh, Pakistan
    Completed

    Not enrolling at this site.

  • Central Prison and Correctional Facility Karachi
    Karachi, Sindh, Pakistan
    Active, not recruiting

    Not enrolling at this site.

  • District Prison & Correctional Facility Malir Karachi
    Karachi, Sindh, Pakistan
    Recruiting
  • Youthful Offenders Industrial School (YOIS)
    Karachi East, Sindh, Pakistan
    Active, not recruiting

    Not enrolling at this site.

08

References and documents

Individual participant data

Plan to share: No — Due to the nature of the research participants and as per the standard operating procedures (SOPs) for research and mental health sessions inside Sindh prison, the researcher has signed to comit full compilance with prison rules and guidelines to ensure confidentiality and data protection.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2025 (actual). Primary completion is estimated for Dec 2026, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2026
First posted
Oct 1, 2026
StartActual
Dec 16, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Apr 2027
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07853352
Lead sponsor
Bahria University
Responsible party
Mahum Azhaar (PhD Scholar, Associate Clinical Psychologist, Bahria University) — Principal investigator
First posted
Oct 1, 2026
Start date
Dec 16, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Apr 2027 (estimated)
Last update
Oct 1, 2026

Study contacts

Mahum Azhaar
principal investigator · Institute of Professional Psychology, Bahria University Karachi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion